⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRAL News
GRAIL, Inc. Common Stock
Form 8-K
sec.gov
GRAL
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
prnewswire.com
GRAL
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting
prnewswire.com
GRAL
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com
GRAL
GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
prnewswire.com
GRAL
GRAIL to Present at the 2026 Jefferies Global Healthcare Conference
prnewswire.com
GRAL
Form 8-K
sec.gov
GRAL
GRAIL Reports First Quarter 2026 Financial Results
prnewswire.com
GRAL
Bronstein, Gewirtz & Grossman, LLC Is Investigating GRAIL, Inc. (GRAL) And Encourages Shareholders to Connect
accessnewswire.com
GRAL
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting
prnewswire.com
GRAL